201 related articles for article (PubMed ID: 15241563)
1. Protective effects of lactoferrin in Escherichia coli-induced bacteremia in mice: relationship to reduced serum TNF alpha level and increased turnover of neutrophils.
Zimecki M; Artym J; Chodaczek G; Kocieba M; Kruzel ML
Inflamm Res; 2004 Jul; 53(7):292-6. PubMed ID: 15241563
[TBL] [Abstract][Full Text] [Related]
2. Lethality in LPS-induced endotoxemia in C3H/HeCr mice is associated with prevalence of proinflammatory cytokines: lack of protective action of lactoferrin.
Zimecki M; Chodaczek G; Kocieba M; Kruzel ML
FEMS Immunol Med Microbiol; 2004 Oct; 42(2):167-72. PubMed ID: 15364100
[TBL] [Abstract][Full Text] [Related]
3. Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin.
Artym J; Zimecki M; Kruzel ML
Int Immunopharmacol; 2004 Sep; 4(9):1149-57. PubMed ID: 15251111
[TBL] [Abstract][Full Text] [Related]
4. Lactoferrin stimulates killing and clearance of bacteria but does not prevent mortality of diabetic mice.
Zagulski T; Jarzabek Z; Zagulska A; Jaszczak M; Kochanowska IE; Zimecki M
Arch Immunol Ther Exp (Warsz); 2001; 49(6):431-8. PubMed ID: 11814237
[TBL] [Abstract][Full Text] [Related]
5. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H
Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792
[TBL] [Abstract][Full Text] [Related]
6. The concerted action of lactoferrin and bacteriophages in the clearance of bacteria in sublethally infected mice.
Zimecki M; Artym J; Kocieba M; Weber-Dabrowska B; Lusiak-Szelachowska M; Górski A
Postepy Hig Med Dosw (Online); 2008 Feb; 62():42-6. PubMed ID: 18268472
[TBL] [Abstract][Full Text] [Related]
7. Early response in septicemia in newborns and their mothers. Effect of Escherichia coli, Streptococcus agalactiae and tumor necrosis factor on lactoferrin release and the generation of tissue thromboplastin.
Gutteberg TJ; Dalaker K; Osterud B; Vorland LH
APMIS; 1991 Jul; 99(7):602-8. PubMed ID: 2069802
[TBL] [Abstract][Full Text] [Related]
8. Normalization of peripheral blood cell composition by lactoferrin in cyclophosphamide-treated mice.
Artym J; Zimecki M; Kruzel M
Med Sci Monit; 2004 Mar; 10(3):BR84-9. PubMed ID: 14976460
[TBL] [Abstract][Full Text] [Related]
9. Lactoferrin regulates the immune responses in post-surgical patients.
Zimecki M; Właszczyk A; Wojciechowski R; Dawiskiba J; Kruzel M
Arch Immunol Ther Exp (Warsz); 2001; 49(4):325-33. PubMed ID: 11726036
[TBL] [Abstract][Full Text] [Related]
10. Endogenous steroids are responsible for lactoferrin-induced myelopoiesis in mice.
Zimecki M; Artym J; Kocieba M
Pharmacol Rep; 2009; 61(4):705-10. PubMed ID: 19815953
[TBL] [Abstract][Full Text] [Related]
11. Lactoferrin increases the output of neutrophil precursors and attenuates the spontaneous production of TNF-alpha and IL-6 by peripheral blood cells.
Zimecki M; Spiegel K; Właszczyk A; Kübler A; Kruzel ML
Arch Immunol Ther Exp (Warsz); 1999; 47(2):113-8. PubMed ID: 10202564
[TBL] [Abstract][Full Text] [Related]
12. Lactoferrin lowers serum interleukin 6 and tumor necrosis factor alpha levels in mice subjected to surgery.
Zimecki M; Właszczyk A; Zagulski T; Kübler A
Arch Immunol Ther Exp (Warsz); 1998; 46(2):97-104. PubMed ID: 9613707
[TBL] [Abstract][Full Text] [Related]
13. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide.
Zanetti G; Heumann D; Gérain J; Kohler J; Abbet P; Barras C; Lucas R; Glauser MP; Baumgartner JD
J Immunol; 1992 Mar; 148(6):1890-7. PubMed ID: 1541827
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
[TBL] [Abstract][Full Text] [Related]
15. Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo.
Machnicki M; Zimecki M; Zagulski T
Int J Exp Pathol; 1993 Oct; 74(5):433-9. PubMed ID: 8217778
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of lactoferrin chimera and bovine lactoferrin in a mouse model of enterohaemorrhagic Escherichia coli O157:H7 infection.
Flores-Villaseñor H; Canizalez-Román A; Velazquez-Roman J; Nazmi K; Bolscher JG; Leon-Sicairos N
Biochem Cell Biol; 2012 Jun; 90(3):405-11. PubMed ID: 22332993
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human lactoferrin has preventive effects on lipopolysaccharide-induced preterm delivery and production of inflammatory cytokines in mice.
Otsuki K; Yakuwa K; Sawada M; Hasegawa A; Sasaki Y; Mitsukawa K; Chiba H; Nagatsuka M; Saito H; Okai T
J Perinat Med; 2005; 33(4):320-3. PubMed ID: 16207117
[TBL] [Abstract][Full Text] [Related]
18. Lactoferrin protects against lipopolysaccharide-induced acute lung injury in mice.
Li XJ; Liu DP; Chen HL; Pan XH; Kong QY; Pang QF
Int Immunopharmacol; 2012 Feb; 12(2):460-4. PubMed ID: 22251871
[TBL] [Abstract][Full Text] [Related]
19. Exogenous carbon monoxide suppresses Escherichia coli vitality and improves survival in an Escherichia coli-induced murine sepsis model.
Shen WC; Wang X; Qin WT; Qiu XF; Sun BW
Acta Pharmacol Sin; 2014 Dec; 35(12):1566-76. PubMed ID: 25399652
[TBL] [Abstract][Full Text] [Related]
20. Immunoregulatory effects of a nutritional preparation containing bovine lactoferrin taken orally by healthy individuals.
Zimecki M; Właszczyk A; Cheneau P; Brunel AS; Mazurier J; Spik G; Kübler A
Arch Immunol Ther Exp (Warsz); 1998; 46(4):231-40. PubMed ID: 9779289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
